Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses
Research and development	$ 2,334	$ 1,981	$ 4,031	$ 3,711
General and administrative	2,335	1,769	4,588	4,620
Total operating expenses	4,669	3,750	8,619	8,331
Loss from operations	(4,669)	(3,750)	(8,619)	(8,331)
Other income (expense)
Interest income	25	0	25	0
Interest expense	(82)	(225)	(225)	(658)
Change in fair value of convertible notes	(387)	(100)	(6,145)	0
Change in fair value of warrants liability	1,880	723	(966)	759
Change in the fair value of the forward purchase agreement derivative liability	0	910	0	(1,308)
Total other income (expense), net	1,436	1,308	(7,311)	(1,207)
Loss before provision for income taxes	(3,233)	(2,442)	(15,930)	(9,538)
Provision for income taxes	3	5	3	5
Net loss	$ (3,236)	$ (2,447)	$ (15,933)	$ (9,543)
Net loss per share:
Net loss per share of common stock, basic	$ (1.03)	$ (4.1)	$ (5.36)	$ (17.06)
Net loss per share of common stock, diluted	$ (1.03)	$ (4.1)	$ (5.36)	$ (17.06)
Weighted-average shares outstanding - basic	3,154,782	597,315	2,975,248	559,385
Weighted-average shares outstanding - diluted	3,154,782	597,315	2,975,248	559,385